AlphaMark Advisors’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-280
Closed -$21K 685
2022
Q3
$21K Buy
+280
New +$21K 0.01% 313